HLA Class II Genes Interact with the Immune Correlates from the RV144 Vaccine Efficacy Trial and Impact HIV-1 Acquisition

被引：0
|
作者：
Prentice, H. [7 ]
Geraghty, D. E. [1 ]
Tomaras, G. D. [2 ]
Fong, Y. [1 ]
Nelson, W. [1 ]
Kijak, G. H. [7 ]
Zolla-Pazner, S. [3 ]
Nitayaphan, S. [4 ]
Rerks-Ngarm, S. [5 ]
Kaewkungwal, J. [6 ]
Pitisuttithum, P. [6 ]
Gilbert, P. B. [1 ]
Haynes, B. F. [2 ]
Kim, J. H. [7 ]
Michael, N.
Thomas, R.
机构：
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[2] Duke Univ, Sch Med, Durham, NC USA
[3] NYU, Sch Med, New York, NY USA
[4] US Army Med Component, AFRIMS, Bangkok, Thailand
[5] Minist Publ Hlth, Nonthanburi, Thailand
[6] Mahidol Univ, Bangkok 10700, Thailand
[7] US MHRP, Silver Spring, MD USA
来源：
AIDS RESEARCH AND HUMAN RETROVIRUSES | 2013年 / 29卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：A178 / A178
页数：1
相关论文
共 50 条
  • [1] Immune Correlates Identified in the RV144 Vaccine Efficacy Trial Impact HIV-1 Acquisition Only in the Presence of Certain HLA Class II Genes
    Prentice, Heather
    Geraghty, Daniel
    Tomaras, Georgia D.
    Fong, Youyi
    Nelson, Wyatt
    Kijak, Gustavo
    Zolla-Pazner, Susan
    Nitayaphan, Sorachai
    Rerks-Ngarm, Supachai
    Kaewkungwal, Jaranit
    Pitisuttithum, Punnee
    Michael, Nelson L.
    Gilbert, Peter
    Kim, Jerome H.
    Thomas, Rasmi
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2014, 30 : A40 - A40
  • [2] Analysis of HLA A☆02 Association with Vaccine Efficacy in the RV144 HIV-1 Vaccine Trial
    Gartland, Andrew J.
    Li, Sue
    McNevin, John
    Tomaras, Georgia D.
    Gottardo, Raphael
    Janes, Holly
    Fong, Youyi
    Morris, Daryl
    Geraghty, Daniel E.
    Kijak, Gustavo H.
    Edlefsen, Paul T.
    Frahm, Nicole
    Larsen, Brendan B.
    Tovanabutra, Sodsai
    Sanders-Buell, Eric
    deCamp, Allan C.
    Magaret, Craig A.
    Ahmed, Hasan
    Goodridge, Jodie P.
    Chen, Lennie
    Konopa, Philip
    Nariya, Snehal
    Stoddard, Julia N.
    Wong, Kim
    Zhao, Hong
    Deng, Wenjie
    Maust, Brandon S.
    Bose, Meera
    Howell, Shana
    Bates, Adam
    Lazzaro, Michelle
    O'Sullivan, Annemarie
    Lei, Esther
    Bradfield, Andrea
    Ibitamuno, Grace
    Assawadarachai, Vatcharain
    O'Connell, Robert J.
    Desouza, Mark S.
    Nitayaphan, Sorachai
    Rerks-Ngarm, Supachai
    Robb, Merlin L.
    Sidney, John
    Sette, Alessandro
    Zolla-Pazner, Susan
    Montefiorl, David
    McElrath, M. Juliana
    Mullins, James I.
    Kim, Jerome H.
    Gilbert, Peter B.
    Hertz, Tomer
    JOURNAL OF VIROLOGY, 2014, 88 (15) : 8242 - 8255
  • [3] HLA class II diversity in HIV-1 uninfected individuals from the placebo arm of the RV144 Thai vaccine efficacy trial
    Baldwin, K. M.
    Ehrenberg, P. K.
    Geretz, A.
    Prentice, H. A.
    Nitayaphan, S.
    Rerks-Ngarm, S.
    Kaewkungwal, J.
    Pitisuttithum, P.
    O'Connell, R. J.
    Kim, J. H.
    Thomas, R.
    TISSUE ANTIGENS, 2015, 85 (02): : 117 - 126
  • [4] Comprehensive Sieve Analysis of Breakthrough HIV-1 Sequences in the RV144 Vaccine Efficacy Trial
    Edlefsen, Paul T.
    Rolland, Morgane
    Hertz, Tomer
    Tovanabutra, Sodsai
    Gartland, Andrew J.
    decamp, Allan C.
    Magaret, Craig A.
    Ahmed, Hasan
    Gottardo, Raphael
    Juraska, Michal
    McCoy, Connor
    Larsen, Brendan B.
    Sanders-Buell, Eric
    Carrico, Chris
    Menis, Sergey
    Bose, Meera
    Arroyo, Miguel A.
    O'Connell, Robert J.
    Nitayaphan, Sorachai
    Pitisuttithum, Punnee
    Kaewkungwal, Jaranit
    Rerks-Ngarm, Supachai
    Robb, Merlin L.
    Kirys, Tatsiana
    Georgiev, Ivelin S.
    Kwong, Peter D.
    Scheffler, Konrad
    Pond, Sergei L. Kosakovsky
    Carlson, Jonathan M.
    Michael, Nelson L.
    Schief, William R.
    Mullins, James I.
    Kim, Jerome H.
    Gilbert, Peter B.
    PLOS COMPUTATIONAL BIOLOGY, 2015, 11 (02)
  • [5] Comprehensive Sieve Analysis of Breakthrough HIV-1 Sequences in the RV144 Vaccine Efficacy Trial
    Edlefsen, Paul T.
    Rolland, Morgane
    Hertz, Tomer
    Tovanabutra, Sodsai
    Gartland, Andrew J.
    deCamp, Allan C.
    Magaret, Craig A.
    Ahmed, Hasan
    Gottardo, Raphael
    Juraska, Michal
    McCoy, Connor
    Larsen, Brendan B.
    Sanders-Buell, Eric
    Carrico, Chris
    Menis, Sergey
    Bose, Meera
    Arroyo, Miguel A.
    O'Connell, Robert J.
    deSouza, Mark S.
    Nitayaphan, Sorachai
    Pitisuttithum, Punnee
    Kaewkungwal, Jaranit
    Rerks-Ngarm, Supachai
    Robb, Merlin L.
    McLellan, Jason S.
    Georgiev, Ivelin S.
    Kirys, Tatsiana
    Kwong, Peter D.
    Carlson, Jonathan M.
    Michael, Nelson L.
    Schief, William R.
    Mullins, James I.
    Kim, Jerome H.
    Gilbert, Peter B.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2014, 30 : A25 - A26
  • [6] Lessons from the RV144 Thai Phase III HIV-1 Vaccine Trial and the Search for Correlates of Protection
    Kim, Jerome H.
    Excler, Jean-Louis
    Michael, Nelson L.
    ANNUAL REVIEW OF MEDICINE, VOL 66, 2015, 66 : 423 - 437
  • [7] Association of FcγRIIC Polymorphism with Vaccine Efficacy and Correlates of HIV-1 Infection Risk in RV144
    Li, S. S.
    Gilbert, P. B.
    Tomaras, G. D.
    Kijak, G.
    Ferrari, G.
    Thomas, R.
    Zolla-Pazner, S.
    Evans, D. T.
    Li, Y.
    Gottardo, R.
    Dai, J. Y.
    Janes, H.
    Morris, D.
    Fong, Y.
    Edlefsen, P. T.
    Li, F.
    Magaret, C. A.
    Frahm, N.
    Alpert, M. D.
    Rerks-Ngarm, S.
    Pitisuttithum, P.
    Kaewkungwal, J.
    Nitayaphan, S.
    Robb, M. L.
    O'Connell, R. J.
    Michael, N. L.
    Kim, J. H.
    McElrath, M. J.
    Geraghty, D. E.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (11) : A178 - A179
  • [8] Evaluating Immune Correlates in HIV Type 1 Vaccine Efficacy Trials: What RV144 May Provide
    Rolland, Morgane
    Gilbert, Peter
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2012, 28 (04) : 400 - 404
  • [9] Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa
    Gray, Glenda E.
    Huang, Ying
    Grunenberg, Nicole
    Laher, Fatima
    Roux, Surita
    Andersen-Nissen, Erica
    De Rosa, Stephen C.
    Flach, Britta
    Randhawa, April K.
    Jensen, Ryan
    Swann, Edith M.
    Bekker, Linda-Gail
    Innes, Craig
    Lazarus, Erica
    Morris, Lynn
    Mkhize, Nonhlanhla N.
    Ferrari, Guido
    Montefiori, David C.
    Shen, Xiaoying
    Sawant, Sheetal
    Yates, Nicole
    Hural, John
    Isaacs, Abby
    Phogat, Sanjay
    DiazGranados, Carlos A.
    Lee, Carter
    Sinangil, Faruk
    Michael, Nelson L.
    Robb, Merlin L.
    Kublin, James G.
    Gilbert, Peter B.
    McElrath, M. Juliana
    Tomaras, Georgia D.
    Corey, Lawrence
    SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (510)
  • [10] FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial
    Li, Shuying S.
    Gilbert, Peter B.
    Tomaras, Georgia D.
    Kijak, Gustavo
    Ferrari, Guido
    Thomas, Rasmi
    Pyo, Chul-Woo
    Zolla-Pazner, Susan
    Montefiori, David
    Liao, Hua-Xin
    Nabel, Gary
    Pinter, Abraham
    Evans, David T.
    Gottardo, Raphael
    Dal, James Y.
    Janes, Holly
    Morris, Daryl
    Fong, Youyi
    Edlefsen, Paul T.
    Li, Fusheng
    Frahm, Nicole
    Alpert, Michael D.
    Prentice, Heather
    Rerks-Ngarm, Supachai
    Pitisuttithum, Punnee
    Kaewkungwal, Jaranit
    Nitayaphan, Sorachai
    Robb, Merlin L.
    O'Connell, Robert J.
    Haynes, Barton F.
    Michael, Nelson L.
    Kim, Jerome H.
    McElrath, M. Juliana
    Geraghty, Daniel E.
    JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (09): : 3879 - 3890
12345